CN1415383A - 外科植入用组织材料改性方法及改性材料 - Google Patents
外科植入用组织材料改性方法及改性材料 Download PDFInfo
- Publication number
- CN1415383A CN1415383A CN 01137562 CN01137562A CN1415383A CN 1415383 A CN1415383 A CN 1415383A CN 01137562 CN01137562 CN 01137562 CN 01137562 A CN01137562 A CN 01137562A CN 1415383 A CN1415383 A CN 1415383A
- Authority
- CN
- China
- Prior art keywords
- organization material
- solution
- coordination compound
- organization
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 80
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000002513 implantation Methods 0.000 title description 4
- 230000002308 calcification Effects 0.000 claims abstract description 26
- 230000008520 organization Effects 0.000 claims description 50
- 210000001519 tissue Anatomy 0.000 claims description 44
- 150000001875 compounds Chemical class 0.000 claims description 39
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 37
- 241000283690 Bos taurus Species 0.000 claims description 31
- 238000004132 cross linking Methods 0.000 claims description 29
- 210000003516 pericardium Anatomy 0.000 claims description 16
- XRSBTDBLFNPGOE-UHFFFAOYSA-M O[Cr] Chemical compound O[Cr] XRSBTDBLFNPGOE-UHFFFAOYSA-M 0.000 claims description 15
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 10
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 10
- 238000012545 processing Methods 0.000 claims description 8
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims description 7
- 239000011651 chromium Substances 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 5
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims description 5
- 235000019253 formic acid Nutrition 0.000 claims description 5
- 229940087654 iron carbonyl Drugs 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 229910052782 aluminium Inorganic materials 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 4
- 229910052804 chromium Inorganic materials 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 230000002490 cerebral effect Effects 0.000 claims description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 210000001951 dura mater Anatomy 0.000 claims description 3
- 210000000109 fascia lata Anatomy 0.000 claims description 3
- 210000004303 peritoneum Anatomy 0.000 claims description 3
- 238000012805 post-processing Methods 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 210000000709 aorta Anatomy 0.000 claims description 2
- 239000012237 artificial material Substances 0.000 claims description 2
- 238000007654 immersion Methods 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 229910052723 transition metal Inorganic materials 0.000 claims 5
- 150000003624 transition metals Chemical class 0.000 claims 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims 2
- 230000010355 oscillation Effects 0.000 claims 2
- 235000017557 sodium bicarbonate Nutrition 0.000 claims 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims 1
- 210000003709 heart valve Anatomy 0.000 abstract description 6
- 238000007385 chemical modification Methods 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 238000012986 modification Methods 0.000 description 28
- 230000004048 modification Effects 0.000 description 28
- 208000004434 Calcinosis Diseases 0.000 description 23
- 239000000243 solution Substances 0.000 description 21
- 102000008186 Collagen Human genes 0.000 description 14
- 108010035532 Collagen Proteins 0.000 description 14
- 229920001436 collagen Polymers 0.000 description 13
- 239000008187 granular material Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 230000005540 biological transmission Effects 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 210000001765 aortic valve Anatomy 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- 238000006460 hydrolysis reaction Methods 0.000 description 4
- 239000003446 ligand Substances 0.000 description 4
- 230000002980 postoperative effect Effects 0.000 description 4
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- PCBMYXLJUKBODW-UHFFFAOYSA-N [Ru].ClOCl Chemical compound [Ru].ClOCl PCBMYXLJUKBODW-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 230000013011 mating Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000012736 aqueous medium Substances 0.000 description 2
- 238000007675 cardiac surgery Methods 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- 206010050559 Aortic valve calcification Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000002473 artificial blood Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 229910001430 chromium ion Inorganic materials 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 201000004541 glycogen storage disease I Diseases 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-N hydroperoxyl Chemical compound O[O] OUUQCZGPVNCOIJ-UHFFFAOYSA-N 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920000447 polyanionic polymer Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000009290 primary effect Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
瓣膜 | 钙含量 | |||
21天 | 60天 | 90天 | 120天 | |
HC(0.1%)改性 | 1.5±0.21 | 1.68±0.24 | 4.67±2.65 | 5.93±2.47 |
GA(0.3%)改性 | 125.0±13.14 | 200.8±21.09 | 230.5±0.21 | 245.56±10.07 |
n | 14 | 14 | 12 | 13 |
Claims (13)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011375620A CN1175910C (zh) | 2001-10-29 | 2001-10-29 | 外科植入用组织材料改性方法及改性材料 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB011375620A CN1175910C (zh) | 2001-10-29 | 2001-10-29 | 外科植入用组织材料改性方法及改性材料 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1415383A true CN1415383A (zh) | 2003-05-07 |
CN1175910C CN1175910C (zh) | 2004-11-17 |
Family
ID=4674225
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB011375620A Expired - Lifetime CN1175910C (zh) | 2001-10-29 | 2001-10-29 | 外科植入用组织材料改性方法及改性材料 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1175910C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178571A (zh) * | 2011-03-28 | 2011-09-14 | 微创医疗器械(上海)有限公司 | 利用声波测量人工生物瓣膜改性程度的装置及方法 |
CN104994893A (zh) * | 2013-02-06 | 2015-10-21 | 生命细胞公司 | 用于组织产物的局部改性的方法 |
CN105326581A (zh) * | 2015-09-29 | 2016-02-17 | 中国科学院金属研究所 | 一种制备聚乙二醇-蛋白质纤维复合人工心脏瓣膜的方法 |
CN115998955A (zh) * | 2022-12-09 | 2023-04-25 | 首都医科大学附属北京安贞医院 | 一种静脉桥的醛铬复合交联方法 |
CN117563049A (zh) * | 2024-01-15 | 2024-02-20 | 北京佰仁医疗科技股份有限公司 | 用于后巩膜加固的眼科生物补片及其制备 |
-
2001
- 2001-10-29 CN CNB011375620A patent/CN1175910C/zh not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102178571A (zh) * | 2011-03-28 | 2011-09-14 | 微创医疗器械(上海)有限公司 | 利用声波测量人工生物瓣膜改性程度的装置及方法 |
CN102178571B (zh) * | 2011-03-28 | 2013-07-17 | 上海微创医疗器械(集团)有限公司 | 利用声波测量人工生物瓣膜改性程度的装置及方法 |
CN104994893A (zh) * | 2013-02-06 | 2015-10-21 | 生命细胞公司 | 用于组织产物的局部改性的方法 |
CN105326581A (zh) * | 2015-09-29 | 2016-02-17 | 中国科学院金属研究所 | 一种制备聚乙二醇-蛋白质纤维复合人工心脏瓣膜的方法 |
CN115998955A (zh) * | 2022-12-09 | 2023-04-25 | 首都医科大学附属北京安贞医院 | 一种静脉桥的醛铬复合交联方法 |
CN117563049A (zh) * | 2024-01-15 | 2024-02-20 | 北京佰仁医疗科技股份有限公司 | 用于后巩膜加固的眼科生物补片及其制备 |
CN117563049B (zh) * | 2024-01-15 | 2024-05-03 | 北京佰仁医疗科技股份有限公司 | 用于后巩膜加固的眼科生物补片及其制备 |
Also Published As
Publication number | Publication date |
---|---|
CN1175910C (zh) | 2004-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bancroft et al. | Connective and other mesenchymal tissues with their stains | |
CA2154294C (en) | Collagen-based matrix | |
Roer et al. | The structure and calcification of the crustacean cuticle | |
EP1347785B1 (de) | Verfahren zur konservierung von biologischen prothesen, konservierte biologische prothese und konservierungslösung | |
WO2021239080A1 (zh) | 一种兼具抗凝血和抗钙化性能的生物瓣膜及其制备方法 | |
CN1175910C (zh) | 外科植入用组织材料改性方法及改性材料 | |
WO2000064371A1 (en) | Stabilization of implantable bioprosthetic devices | |
CN110511419A (zh) | 一种改善碳纤维增强聚醚醚酮复合材料表面生物活性的方法 | |
CN111068121A (zh) | 一种木质基仿生骨支架材料的制备方法 | |
CN112472871B (zh) | 一种提高力学及抗凝血性能的生物瓣膜交联方法 | |
CN1233425C (zh) | 层-层自组装固定生物活性因子于组织工程材料上的方法 | |
Braga-Vilela et al. | Extracellular matrix of porcine pericardium: biochemistry and collagen architecture | |
Endean | Studies of the blood and tests of some Australian ascidians. II. The test of Pyura stolonifera (Heller) | |
CN1294254C (zh) | 异种心血管移植物的脱细胞方法 | |
CN113289064A (zh) | 一种双网络水凝胶修饰的生物心脏瓣膜及其制备方法 | |
CN1371750A (zh) | 生物心脏瓣膜2,3-丁二醇防钙化改性的方法 | |
CN1557538A (zh) | 高分子树脂型胆红素吸附剂的制备方法 | |
Ehrlich et al. | Marine collagens | |
CN1093566A (zh) | 胶原组织材料缓钙化复合环氧交联法 | |
CN112263715B (zh) | 一种抗凝血抗钙化的人工心脏瓣膜材料及其制备方法与应用 | |
Watanabe | Histochemical studies on mucosubstances in urinary stones | |
EP3876869B1 (en) | The system of an element used for the creation of heart valve, the method of manufacturing of modified bacterial cellulose (bc), the set and the element used in cardio surgery | |
CN101766842A (zh) | 人工器官用生物组织材料及其制备方法 | |
CN1117586C (zh) | 一种人工心脏瓣膜生物材料的加工方法 | |
RU2558089C1 (ru) | Способ предимплантационной обработки биологических протезов для сердечно-сосудистой хирургии |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: BEIJING BAIREN MEDICAL TREATMENT SCIENCE CO., LTD Free format text: FORMER OWNER: JIN LEI Effective date: 20061013 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20061013 Address after: 102200 No. 6 Spark Street, Changping science and Technology Park, Beijing Patentee after: BEIJING BAIREN MEDICAL TECHNOLOGY Address before: 102200 No. 6 Spark Street, Changping science and Technology Park, Beijing Patentee before: Jin Lei |
|
CP01 | Change in the name or title of a patent holder |
Address after: 102200 No. 6 Spark Street, Changping science and Technology Park, Beijing Patentee after: Beijing Bai Ren medical Polytron Technologies Inc Address before: 102200 No. 6 Spark Street, Changping science and Technology Park, Beijing Patentee before: BEIJING BAIREN MEDICAL TECHNOLOGY |
|
CP01 | Change in the name or title of a patent holder | ||
DD01 | Delivery of document by public notice |
Addressee: Beijing Bai Ren medical Polytron Technologies Inc Document name: Notification of Passing Examination on Formalities |
|
DD01 | Delivery of document by public notice | ||
CP02 | Change in the address of a patent holder |
Address after: 102200 2 Beijing Hua Chang Road, Changping District Science Park. Patentee after: Beijing Bai Ren medical Polytron Technologies Inc Address before: 102200 No. 6 Spark Street, Changping science and Technology Park, Beijing Patentee before: Beijing Bai Ren medical Polytron Technologies Inc |
|
CP02 | Change in the address of a patent holder | ||
CX01 | Expiry of patent term |
Granted publication date: 20041117 |
|
CX01 | Expiry of patent term |